Skip to Main Content

Author Details

Natalia A Kuzmina
University of Texas Medical Branch, USA Galveston National Laboratory
2012
39
16
PMIDPaper TitleJournal TitlePublished Year
36763096Coronavirus Immunotherapeutic Consortium Database.Database (Oxford)2023
37858466Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin.Cell Rep2023
37243162Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24.Viruses2023
37131834Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system.Res Sq2023
36287714A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.Emerg Microbes Infect2022
35479098Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19.Front Immunol2022
35584193Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region.PLoS Pathog2022
35468973A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2.NPJ Vaccines2022
36374040Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection.Microbiol Spectr2022
36192374IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern.Nat Commun2022
33427208Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022.JCI Insight2021
33852862Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies.Cell Rep2021
33619476COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.Res Sq2021
33865504SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.Lancet Respir Med2021
34671037COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.Nat Commun2021
34781240Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2.J Clin Virol2021
34715022Pan-ebolavirus protective therapy by two multifunctional human antibodies.Cell2021
34294728A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19.NPJ Vaccines2021
34289361Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection.Cell Rep2021
34261800Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects.Sci Transl Med2021
33951434Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection.Cell Rep2021
32320678Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.Cell Host Microbe2020
32023489Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization.Immunity2020
29736037Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region.Nat Microbiol2018
30029854Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein.Immunity2018
30060231Ebolavirus Chimerization for the Development of a Mouse Model for Screening of Bundibugyo-Specific Antibodies.J Infect Dis2018
30138408Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap.PLoS Pathog2018
30110637Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors.Cell Rep2018
30270905In Vivo Efficacy of a Cocktail of Human Monoclonal Antibodies (CL184) Against Diverse North American Bat Rabies Virus Variants.Trop Med Infect Dis2017
26819310Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies.J Virol2016
26806128Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection.Cell2016
24038455Phylogenetic and epidemiologic evidence of multiyear incubation in human rabies.Ann Neurol2014
25080103Bat rabies in Guatemala.PLoS Negl Trop Dis2014
23137052Multidisciplinary approach to epizootiology and pathogenesis of bat rabies viruses in the United States.Zoonoses Public Health2013
24312657The phylogeography and spatiotemporal spread of south-central skunk rabies virus.PLoS One2013
23917290Raccoon rabies virus variant transmission through solid organ transplantation.JAMA2013
23839669A reassessment of the evolutionary timescale of bat rabies viruses based upon glycoprotein gene sequences.Virus Genes2013
23742991An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines.Vaccine2013
22737076Molecular inferences suggest multiple host shifts of rabies viruses from bats to mesocarnivores in Arizona during 2001-2009.PLoS Pathog2012
  • 1 - 39 of 39

Recommended Authors

James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 8
Carolina Lucas
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Laura A VanBlargan
Washington University School of Medicine
Career Start Year 2013
Number of shared co-authors 9
Nicholas Dambrauskas
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Career Start Year 2013
Number of shared co-authors 2
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 2
Xuping Xie
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 7
Kenneth S Plante
University of Texas Medical Branch
Career Start Year 2009
Number of shared co-authors 5
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 6
Melissa M Coughlin
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 0
Shannan L Rossi
Institute for Human Infection and Immunity, University of Texas Medical Branch
Career Start Year 2005
Number of shared co-authors 2
David Noah Sather
Center for Global Infectious Disease Research, Seattle Children's Hospital
Career Start Year 2005
Number of shared co-authors 5
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 4
Lingshu Wang
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year 2003
Number of shared co-authors 4
Natalie J Thornburg
Centers for Disease Control and Prevention (CDC)
Career Start Year 2003
Number of shared co-authors 12
Fabian Schmidt
The Rockefeller University
Career Start Year 2002
Number of shared co-authors 3
Kayvon Modjarrad
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 0
Kimberly Meade-White
National Institutes of Allergy and Infectious Disease, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 1
Encheng Sun
Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences
Career Start Year 2000
Number of shared co-authors 0
Mansun Law
The Scripps Research Institute
Career Start Year 1998
Number of shared co-authors 3
Gary P Kobinger
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 9
Theodora Hatziioannou
The Rockefeller University
Career Start Year 1995
Number of shared co-authors 3
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 9
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 6
James E Strong
University of Manitoba
Career Start Year 1991
Number of shared co-authors 3
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Career Start Year 1991
Number of shared co-authors 6
Juergen A Richt
College of Veterinary Medicine, Kansas State University
Career Start Year 1988
Number of shared co-authors 7
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 3
Michael S Diamond
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 13
Ruth M Ruprecht
University of Texas San Antonio
Career Start Year 1971
Number of shared co-authors 1
Clarence J Peters
University of Texas Medical Branch at Galveston
Career Start Year 1970
Number of shared co-authors 5

Collaborators

James E Crowe
Vanderbilt University Medical Center
Co-authored papers 17
Pavlo Gilchuk
Vanderbilt University Medical Center
Co-authored papers 10
Galit Alter
Co-authored papers 9
Charles E Rupprecht
College of Forestry, Auburn University
Co-authored papers 8
Ivan V Kuzmin
University of Texas Medical Branch
Co-authored papers 6
Bronwyn M Gunn
Co-authored papers 6
Pamela Yager
Centers for Disease Control and Prevention
Co-authored papers 3
Ralph S Baric
University of North Carolina
Co-authored papers 3
Robert H Carnahan
Vanderbilt University Medical Center
Co-authored papers 3
Stuart C Sealfon
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Ian A Wilson
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Co-authored papers 2
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Lynda Coughlan
University of Maryland
Co-authored papers 2
Preeti Bharaj
University of Texas Medical Branch
Co-authored papers 2
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Co-authored papers 2
David C Montefiori
Co-authored papers 2
Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Co-authored papers 2
Sarah R Leist
University of North Carolina at Chapel Hill
Co-authored papers 2
Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Torrey A Boland
Rush University Medical Center
Co-authored papers 1
Jenelle Jindal
El Camino Hospital
Co-authored papers 1
Jean-Jacques Muyembe-Tamfum
National Institute of Biomedical Research (INRB)
Co-authored papers 1
James A Overton
Knocean Inc.
Co-authored papers 1
Randi Vita
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers 1
Nadia Storm
Harvard Medical School
Co-authored papers 1
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Karthik Gangavarapu
the Scripps Research Institute
Co-authored papers 1
Marcelo Rocha
University of Pittsburgh
Co-authored papers 1
Todd J Suscovich
Co-authored papers 1
Melanie D Ohi
Co-authored papers 1
Release 1.2